Basic info
Industry
biotechnology research
Sectors
Biotechnology
Life Science
autoimmune diseases
Immunoprofiling
infectious diseases
immunomonitoring
CyTOF
T cell antigens
neoantigen
immunotherapy
oncology
biomarker
cytographer
Medical
vaccine
mass cytometry
Date founded
2016
Funding rounds raised
Total raised
$14M
from 5 investors over 5 rounds
i
immunoSCAPE raised $14M on September 20, 2022
Investors: Anzu Partners and EDBI Pte Ltd
i
immunoSCAPE raised $14M on April 14, 2021
Investors: Anzu Partners and EDBI Pte Ltd
i
immunoSCAPE raised $11M on August 12, 2020
Investors: Anzu Partners